Physician profile
Stewart A Sharp
NPI 1235124934
$2,013.74
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,802 · 2020: $212.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $417.49 | 2019 | |
| Merck Sharp & Dohme LLC | $255.21 | 2019 | |
| Genentech USA, INC. | $203.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $200.69 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $171.82 | 2019-2020 | |
| Genzyme Corporation | $98.08 | 2019 | |
| Lilly USA, LLC | $71.11 | 2019 | |
| Gilead Sciences, INC. | $62.05 | 2019-2020 | |
| Pfizer INC. | $60.54 | 2019 | |
| Janssen Biotech, INC. | $52.15 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $46.25 | 2019 | |
| Celgene Corporation | $38.72 | 2019 | |
| Seagen INC. | $36.78 | 2019-2020 | |
| Eisai INC. | $35.77 | 2019 | |
| Emd Serono, INC. | $30.12 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $29.44 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $28.02 | 2019 | |
| Sandoz INC. | $23.46 | 2020 | |
| Astellas Pharma US INC | $20.28 | 2020 | |
| Clovis Oncology, INC. | $19.89 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $18.31 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.28 | 2020 | |
| Daiichi Sankyo INC. | $16.48 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.19 | 2019 | |
| Exelixis INC. | $15.93 | 2019 | |
| Glaxosmithkline, LLC. | $15.73 | 2020 | |
| Incyte Corporation | $12.52 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stewart Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.